We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Sequential Therapy With WLL/Inhaling GM-CSF for Autoimmune Pulmonary Alveolar Proteinosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03316651
Recruitment Status : Unknown
Verified September 2017 by Dai Huaping, China-Japan Friendship Hospital.
Recruitment status was:  Recruiting
First Posted : October 20, 2017
Last Update Posted : October 20, 2017
Information provided by (Responsible Party):
Dai Huaping, China-Japan Friendship Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : December 2019
Estimated Study Completion Date : December 2020